Use of psychotropic medications for persons with mental retardation who live in Oklahoma nursing homes

Psychiatric Services

Volumn 49, Issue 4, 1998, Pages 510-512

  Spreat, Scott ^a   Conroy, James ^b  

^a Woods Services   (United States)

^b Center for Outcome Analysis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; CHLORPROMAZINE; DIAZEPAM; HALOPERIDOL; THIORIDAZINE; VALPROATE SEMISODIUM;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; NURSING HOME; PRESCRIPTION; TREATMENT PLANNING;

EID: 0031901260     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.49.4.510     Document Type: Article

References (11)

1. Braddock D, Hemp R, Fujiura G, et al: The State of the States in Developmental Disabilities. Baltimore, Brookes, 1989
2. Amado A, Lakin C, Menke J: 1990 Chartbook on Services for People With Developmental Disabilities. Minneapolis, University of Minnesota, Center for Residential and Community Services, 1990
3. Lakin C, Hill B, Anderson D: Persons With Mental Retardation in Nursing Homes in 1977 and 1985: A Comparison of Findings From the 1977 and 1985 National Nursing Home Surveys. Brief no 31. Minneapolis, Minnesota University Affiliated Program on Developmental Disabilities, 1988
4. Davis R, Silverstein B, Uehara E, et al: Evaluation and Service Identification Project for Developmentally Disabled Residents of Intermediate Care and Skilled Nursing Facilities. Chicago, Taylor Institute, 1987
5. Aman M, Singh N: Patterns of drug use, methodological considerations, measurement techniques, and future trends, in Psychopharmacology of the Developmental Disabilities Edited by Aman M, Singh N. New York, Springer-Verlag, 1988
6. Spreat S, Conroy J, Jones J: Use of psychotropic medication in Oklahoma: a statewide survey. American Journal of Mental Retardation 102:80-85, 1997
7. Developmental Disabilities Quality Assurance Questionnaire. Stillwater, Oklahoma State University, Department of Sociology, 1982
8. AMA Drug Evaluations. Chicago, American Medical Association, 1978
9. Aman M, Sarphare G, Burrow W: Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables. American Journal of Mental Retardation 99:500-509, 1985
10. Klawans H, Goetz C, Perlik S: Tardive dyskinesia: review and update. American Journal of Psychiatry 137:900-908, 1980
11. Spreat S, Serafin C, Behar D, et al: Tranquilizer reduction trials in a residential program for persons with mental retardation. Hospital and Community Psychiatry 44: 1100-1102, 1993